Bausch Health Companies Inc (BHC)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: BHC Exchange: TOR


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-04 2024-03-04 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
133 -0.0%
9.80
1,303 USD 		133 -0.0% 9.80 1,303 USD
2024-03-04 2024-03-04 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
1,561 -0.3%
9.80
15,298 USD 		1,561 -0.3% 9.80 15,298 USD
2024-03-04 2024-03-04 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
199 -0.0%
9.80
1,950 USD 		199 -0.0% 9.80 1,950 USD
2024-03-04 2024-03-04 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
4,420 -0.9%
9.80
43,316 USD 		4,420 -0.9% 9.80 43,316 USD
2023-12-05 2023-12-05 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
220 -0.1%
7.38
1,624 USD 		220 -0.1% 7.38 1,624 USD
2023-11-06 2023-11-06 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
43 -0.0%
7.61
327 USD 		43 -0.0% 7.61 327 USD
2023-09-06 2023-09-06 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
6,685 -1.7%
8.28
55,352 USD 		6,685 -1.7% 8.28 55,352 USD
2023-03-01 2023-02-28 PS Planned sale

Carson Seana

EVP, General Counsel

Officer
292 -0.1%
9.32
2,721 USD 		292 -0.1% 9.32 2,721 USD
2022-04-15 2022-04-14 PS Planned sale

Spurr Robert

U.S. President-Pharma Business

Officer
1,595 -1.7%
22.19
35,393 USD 		1,595 -1.7% 22.19 35,393 USD
2022-03-16 2022-03-15 PS Planned sale

Spurr Robert

U.S. President-Pharma Business

Officer
4,846 -5.0%
22.20
107,581 USD 		4,846 -5.0% 22.20 107,581 USD
2022-03-10 2022-03-08 PS Planned sale

Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
3,889 -4.0%
21.76
84,625 USD 		3,889 -4.0% 21.76 84,625 USD
2022-03-04 2022-03-02 PS Planned sale

Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
11,077 -9.9%
23.37
258,869 USD 		11,077 -9.9% 23.37 258,869 USD
2022-03-04 2022-03-02 PS Planned sale

Spurr Robert

U.S. President-Pharma Business

Officer
1,595 -2.4%
23.37
37,275 USD 		1,595 -2.4% 23.37 37,275 USD
2022-03-02 2022-03-01 PS Planned sale

Gordon Joseph F

Pres&Co-Head Bausch&Lomb/Int'l

Officer
6,338 -5.3%
23.82
150,971 USD 		6,338 -5.3% 23.82 150,971 USD
2022-02-17 2022-02-15 PS Planned sale

Spurr Robert

U.S. President-Pharma Business

Officer
3,251 -5.1%
25.02
81,340 USD 		3,251 -5.1% 25.02 81,340 USD
2022-01-20 2022-01-18 PS Planned sale

Spurr Robert

U.S. President-Pharma Business

Officer
3,251 -4.9%
26.63
86,574 USD 		3,251 -4.9% 26.63 86,574 USD
2021-12-02 2021-11-30 B Purchase

Miller Steven D

Non-Executive Director
10,000 +inf%
24.17
241,699 USD 		10,000 +inf% 24.17 241,699 USD
2021-12-02 2021-11-30 B Purchase

Miller Steven D

Non-Executive Director
50,000 +463.8%
24.24
1,211,825 USD 		50,000 +463.8% 24.24 1,211,825 USD
2021-06-15 2021-06-11 S Sale

Eldessouky Sam

EVP & Chief Financial Officer

Officer
17,000 -12.7%
31.68
538,586 USD 		17,000 -12.7% 31.68 538,586 USD
2020-12-08 2020-12-04 S Sale

Humphries William D.

President, Ortho-Dermatologics

Officer
114,055 -32.7%
19.87
2,266,398 USD 		114,055 -32.7% 19.87 2,266,398 USD
2020-11-30 2020-11-27 S Sale

Humphries William D.

President, Ortho-Dermatologics

Officer
13,663 -5.5%
19.63
268,207 USD 		13,663 -5.5% 19.63 268,207 USD
2020-11-30 2020-11-24 S Sale

Humphries William D.

President, Ortho-Dermatologics

Officer
21,658 -8.4%
19.63
425,196 USD 		21,658 -8.4% 19.63 425,196 USD
2020-11-30 2020-11-23 S Sale

Humphries William D.

President, Ortho-Dermatologics

Officer
1,483 -0.6%
19.63
29,115 USD 		1,483 -0.6% 19.63 29,115 USD
2020-09-10 2020-09-08 PS Planned sale

Humphries William D.

President, Ortho-Dermatologics

Officer
5,667 -2.4%
16.17
91,635 USD 		5,667 -2.4% 16.17 91,635 USD
2020-06-09 2020-06-05 B Purchase

ValueAct Holdings, L.P.

See Remarks

Non-Executive Director
948,353 +5.6%
19.24
18,246,312 USD 		948,353 +5.6% 19.24 18,246,312 USD
2020-06-09 2020-06-05 S Sale

ValueAct Holdings, L.P.

See Remarks

Non-Executive Director
948,353 -100.0%
19.24
18,246,312 USD 		948,353 -100.0% 19.24 18,246,312 USD
2020-05-14 2020-05-14 B Purchase

Paulson John

Non-Executive Director
585,100 +2.3%
15.92
9,314,792 USD 		585,100 +2.3% 15.92 9,314,792 USD
2020-05-14 2020-05-14 B Purchase

Paulson John

Non-Executive Director
624,900 +2.5%
15.87
9,917,163 USD 		624,900 +2.5% 15.87 9,917,163 USD
2020-05-14 2020-05-14 B Purchase

Paulson John

Non-Executive Director
70,000 +0.3%
15.65
1,095,500 USD 		70,000 +0.3% 15.65 1,095,500 USD
2020-05-14 2020-05-14 B Purchase

Paulson John

Non-Executive Director
348,920 +1.4%
15.85
5,530,382 USD 		348,920 +1.4% 15.85 5,530,382 USD
2020-05-14 2020-05-13 B Purchase

Paulson John

Non-Executive Director
645,844 +2.7%
16.70
10,785,595 USD 		645,844 +2.7% 16.70 10,785,595 USD
2020-05-14 2020-05-13 B Purchase

Paulson John

Non-Executive Director
80,300 +0.3%
16.58
1,331,374 USD 		80,300 +0.3% 16.58 1,331,374 USD
2020-05-14 2020-05-13 B Purchase

Paulson John

Non-Executive Director
603,900 +2.6%
16.32
9,855,648 USD 		603,900 +2.6% 16.32 9,855,648 USD
2020-05-14 2020-05-12 B Purchase

Paulson John

Non-Executive Director
799,900 +3.6%
17.24
13,790,276 USD 		799,900 +3.6% 17.24 13,790,276 USD
2020-05-14 2020-05-12 B Purchase

Paulson John

Non-Executive Director
678,400 +3.2%
17.47
11,851,648 USD 		678,400 +3.2% 17.47 11,851,648 USD
2020-05-14 2020-05-12 B Purchase

Paulson John

Non-Executive Director
374,836 +1.8%
17.33
6,495,908 USD 		374,836 +1.8% 17.33 6,495,908 USD
2020-05-14 2020-05-12 B Purchase

Paulson John

Non-Executive Director
162,900 +0.8%
17.50
2,850,750 USD 		162,900 +0.8% 17.50 2,850,750 USD
2020-05-14 2020-05-12 B Purchase

Paulson John

Non-Executive Director
25,000 +0.1%
17.30
432,500 USD 		25,000 +0.1% 17.30 432,500 USD
2020-03-16 2020-03-12 B Purchase

Ross Thomas W. Sr.

Non-Executive Director
2,500 +3.3%
15.54
38,838 USD 		2,500 +3.3% 15.54 38,838 USD
2020-03-11 2020-03-10 B Purchase

VON ESCHENBACH ANDREW C.

Non-Executive Director
1,100 +6.3%
18.18
19,996 USD 		1,100 +6.3% 18.18 19,996 USD
2020-03-11 2020-03-10 B Purchase

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL

Officer
4,390 +5.0%
18.25
80,106 USD 		4,390 +5.0% 18.25 80,106 USD
2020-03-11 2020-03-10 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
3,800 +38.0%
18.26
69,377 USD 		3,800 +38.0% 18.26 69,377 USD
2020-03-11 2020-03-03 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
5,000 +1.8%
23.08
115,415 USD 		5,000 +1.8% 23.08 115,415 USD
2019-09-13 2019-09-13 B Purchase

PAPA JOSEPH C

CHAIRMAN & CEO

Executive Director
30,000 +3.7%
23.31
699,300 USD 		30,000 +3.7% 23.31 699,300 USD
2019-08-21 2019-08-19 S Sale

McKenna Mark C.

President, Salix

Officer
10,773 -34.2%
21.83
235,221 USD 		10,773 -34.2% 21.83 235,221 USD
2019-08-20 2019-08-16 B Purchase

Humphries William D.

President, Ortho-Dermatologics

Officer
30,703 +26.2%
21.18
650,142 USD 		30,703 +26.2% 21.18 650,142 USD
2019-08-13 2019-08-12 PS Planned sale

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL

Officer
3,418 -6.3%
22.45
76,726 USD 		3,418 -6.3% 22.45 76,726 USD
2019-07-15 2019-07-11 PS Planned sale

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL
3,968 -6.0%
24.81
98,446 USD 		3,968 -6.0% 24.81 98,446 USD
2019-02-28 2019-02-28 B Purchase

PAPA JOSEPH C

CHAIRMAN & CEO

Executive Director
30,000 +4.4%
23.67
710,100 USD 		30,000 +4.4% 23.67 710,100 USD
2018-12-18 2018-12-14 B Purchase

APPIO THOMAS

Pres&Co-Head Bausch&Lomb/Int'l

Officer
25,440 +24.6%
22.96
584,018 USD 		25,440 +24.6% 22.96 584,018 USD
2018-10-17 2018-10-16 PS Planned sale

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL

Officer
4,542 -8.1%
25.50
115,821 USD 		4,542 -8.1% 25.50 115,821 USD
2018-10-17 2018-10-15 PS Planned sale

ACKERMANN CHRISTINA

EVP AND GENERAL COUNSEL

Officer
15,404 -21.6%
24.83
382,481 USD 		15,404 -21.6% 24.83 382,481 USD
2018-09-17 2018-09-14 B Purchase

PAPA JOSEPH C

CHAIRMAN & CEO

Executive Director
30,000 +4.8%
22.32
669,600 USD 		30,000 +4.8% 22.32 669,600 USD
2018-09-17 2018-09-14 B Purchase

Herendeen Paul

EVP and CFO

Officer
10,000 +4.8%
22.61
226,100 USD 		10,000 +4.8% 22.61 226,100 USD
2018-09-17 2018-09-13 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
125,000 +92.8%
23.96
2,995,000 USD 		125,000 +92.8% 23.96 2,995,000 USD
2018-07-03 2018-05-15 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
10,000 +inf%
21.80
218,000 USD 		10,000 +inf% 21.80 218,000 USD
2018-05-17 2018-05-15 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
15,000 +12.7%
21.83
327,450 USD 		15,000 +12.7% 21.83 327,450 USD
2018-03-13 2018-03-13 B Purchase

Herendeen Paul

EVP and CFO
15,000 +6.9%
16.10
241,470 USD 		15,000 +6.9% 16.10 241,470 USD
2018-03-13 2018-03-13 B Purchase

PAPA JOSEPH C

CHAIRMAN & CEO

Executive Director
30,000 +4.4%
16.05
481,500 USD 		30,000 +4.4% 16.05 481,500 USD
2018-03-12 2018-03-08 B Purchase

DE SCHUTTER RICHARD U

10,000 +10.4%
15.34
153,400 USD 		10,000 +10.4% 15.34 153,400 USD
2018-03-08 2018-03-06 B Purchase

Paulson John

7,066,629 +51.3%
15.40
108,826,087 USD 		7,066,629 +51.3% 15.40 108,826,087 USD
2018-03-08 2018-03-06 S Sale

Paulson John

7,066,629 -33.9%
15.40
108,826,087 USD 		7,066,629 -33.9% 15.40 108,826,087 USD
2017-11-21 2017-11-17 B Purchase

DE SCHUTTER RICHARD U

10,000 +11.8%
14.33
143,300 USD 		10,000 +11.8% 14.33 143,300 USD
2017-11-20 2017-11-16 S Sale

Paulson John

344,216 -1.6%
14.39
4,952,821 USD 		344,216 -1.6% 14.39 4,952,821 USD
2017-11-20 2017-11-16 B Purchase

Paulson John

344,216 +1.7%
14.40
4,955,506 USD 		344,216 +1.7% 14.40 4,955,506 USD
2017-08-22 2017-08-21 B Purchase

DE SCHUTTER RICHARD U

4,900 +6.3%
14.35
70,315 USD 		4,900 +6.3% 14.35 70,315 USD
2017-08-22 2017-08-21 B Purchase

DE SCHUTTER RICHARD U

5,100 +7.0%
14.31
72,981 USD 		5,100 +7.0% 14.31 72,981 USD
2017-05-15 2017-05-11 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
20,000 +39.5%
13.90
278,000 USD 		20,000 +39.5% 13.90 278,000 USD
2017-03-16 2017-03-15 B Purchase

DE SCHUTTER RICHARD U

Non-Executive Director
10,000 +65.8%
10.80
108,000 USD 		10,000 +65.8% 10.80 108,000 USD
2017-03-16 2017-03-14 B Purchase

Herendeen Paul

EVP and CFO
24,000 +16.0%
10.72
257,280 USD 		24,000 +16.0% 10.72 257,280 USD
2017-03-16 2017-03-14 B Purchase

ValueAct Holdings, L.P.

See Remarks
2,500,000 +17.3%
10.81
27,025,000 USD 		2,500,000 +17.3% 10.81 27,025,000 USD
2017-03-16 2017-03-14 B Purchase

ValueAct Holdings, L.P.

See Remarks
500,000 +3.6%
10.88
5,440,000 USD 		500,000 +3.6% 10.88 5,440,000 USD
2017-03-14 2017-03-13 S Sale

Pershing Square Capital Management, L.P.

Non-Executive Director
18,114,432 -100.0%
11.00
199,258,752 USD 		18,114,432 -100.0% 11.00 199,258,752 USD
2016-12-16 2016-12-14 B Purchase

Ross Thomas W. Sr.

Non-Executive Director
5,000 +22.9%
14.73
73,650 USD 		5,000 +22.9% 14.73 73,650 USD
2016-12-13 2016-12-12 S Sale

Pershing Square Capital Management, L.P.

Non-Executive Director
3,476,690 -16.1%
14.85
51,628,847 USD 		3,476,690 -16.1% 14.85 51,628,847 USD